O'CALLAGHAN BRIAN 4
4 · Bolt Biotherapeutics, Inc. · Filed Mar 28, 2022
Insider Transaction Report
Form 4
O'CALLAGHAN BRIAN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-24+22,140→ 22,140 totalExercise: $3.03Exp: 2032-03-23→ Common Stock (22,140 underlying) - Award
Stock Option (Right to Buy)
2022-03-24+14,071→ 14,071 totalExercise: $3.03Exp: 2032-03-23→ Common Stock (14,071 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.
- [F2]The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.